Skip to main content

ADVERTISEMENT

Ameka Coleman, MS, BS

Original Contribution
10/01/2015
Intermediate SVG lesions have high rates of progression. The purpose of this study was to examine the impact of extended-release niacin (ER-niacin) vs. placebo on intermediate saphenous vein graft (SVG) lesions.
Intermediate SVG lesions have high rates of progression. The purpose of this study was to examine the impact of extended-release niacin (ER-niacin) vs. placebo on intermediate saphenous vein graft (SVG) lesions.
Intermediate SVG lesions have...
10/01/2015
Journal of Invasive Cardiology